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Neurofibromatosis (NF) consists of at least two geneti-
cally distinct disorders: NF-1 (von Recklinghausen’s or 
peripheral neurofibromatosis) and NF-2, which is formerly 
known as central neurofibromatosis [1-3]. NF-1, first ob-
served by von Recklinghausen, manifests clinically in 
infancy with multiple cafe-au-lait skin spots, intertriginous 
freckling, iris hamartomas (Lisch nodules) and multiple 
cutaneous neurofibromas and is caused by genetic ab-
normalities on chromosome 17. NF-2 is characterized by 
bilateral vestibular schwannomas (acoustic neuromas) 
and brain and spinal cord tumors, and it is transmitted by 
genetic abnormalities on chromosome 22. The prevalence 
of NF-1 is approximately 1 in 2,500 to 3,300 individuals, 
while NF-2 is observed in approximately 1 in 50,000 to 
120,000 individuals, regardless of race, sex, or ethnicity 
[2,4].
NF can involve multiple organs, and the ocular manifes-
tations of NF-1 include multiple iris hamartomas (Lisch 
nodules), congenital glaucoma, optic nerve gliomas, plexi-
form neurofibromas of the eyelids, and uveal hamartomas. 
On the other hand, retinal or choroidal lesions are rarely 
involved in the patients with NF-1 [5-8]. Furthermore, NF-1 
patients tend to not undergo detailed ophthalmic examina-
tions since NF-1 is rarely a vision-threatening disorder. In 
this study, we report two cases of choroidal abnormalities 
occurring in NF patients which were detected by fluores-
ceine angiography (FA) and indocyanine green angiogra-
phy (ICGA) in patients with NF-1 that had obscure fundus 
findings but good vision.
Case Reports
Case 1
The following is a case of a 59-year-old female who had 
previously been diagnosed with NF type 1. She was re-
ferred to the Retina Clinic at Uijeongbu St. Mary’s Hospi-
tal with the complaint of blurred vision for several months. 
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We report two cases of choroidal neurofibromatosis, detected with the aid of indocyanine green angiography 
(ICGA) in patients with neurofibromatosis (NF)-1, otherwise having obscure findings based on ophthalmoscopy 
and fluoresceine angiography (FA). In case 1, the ophthalmoscopic exam showed diffuse bright or yellowish 
patched areas with irregular and blunt borders at the posterior pole. The FA showed multiple hyperfluorescent 
areas at the posterior pole in the early phase, which then showed more hyperfluorescence without leakage or 
extent in the late phase. The ICGA showed diffuse hypofluorescent areas in both the early and late phases, and 
the deep choroidal vessels were also visible. In case 2, the fundus showed no abnormal findings, and the FA 
showed weakly hypofluorescent areas with indefinite borders in both eyes. With the ICGA, these areas were 
more hypofluorescent and had clear borders. Choroidal involvement in NF-1 seems to occur more than expect-
ed. In selected cases, ICGA is a useful tool to be utilized when an ocular examination is conducted in a patient 
that has no definite findings based on the ophthalmoscope, B-scan, or FA tests.
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Diagnosis was confirmed at the age of 55 years, and both 
her mother and sister had the same disease. Upon ocular 
examination, she had multiple iris hamartomas (Lisch nod-
ule), and intraocular lenses with posterior capsular opacity 
in both eyes. The patient had cataract surgeries in both 
eyes 2 years prior to our examination. Her visual acuity 
was 20 / 120 in the right eye and 20 / 60 in the left eye at 
the time of her initial visit. After laser capsulotomy, the vi-
sion in both of her eyes improved to 20 / 20. At the follow-
up visit, the fundoscopic exam showed diffuse bright or 
yellowish patched areas with irregular and blunt borders 
at the posterior pole. Although alterations were not clearly 
visible by fundoscopy, there was a slightly patched pattern 
or an uneven surface on the posterior pole (Fig. 1A). The 
FA showed multiple hyperfluorescent areas at the posterior 
pole in the early phase, and then these areas showed more 
hyperfluorescence without leakage and were extent in the 






Fig. 1. Case 1. Diffuse bright or yellowish patched areas with ir-
regular and blunt borders at the posterior pole (A). Early-phase 
fluorescein angiography of the same eye shows several hyperfluo-
rescent areas at the posterior pole, and these areas correspond to the 
bright patched areas that are seen in fundoscopy. These represent 
the zones of retinal pigmented epithelium alterations. These areas 
appear more hyperfluorescent with the same extent in the late phase 
(B,C). Indocyanine green angiography showed diffuse hypofluores-
cent areas in both the early and late phases, and the deep choroidal 
vessels are visible within the hypofluorescent area (D,E).232
Korean J Ophthalmol Vol.26, No.3, 2012
the multiple yellowish patched lesions that were invisible 
in fundoscopy. The ICGA showed diffuse hypofluorescent 
areas in both the early and late phase, and the deep choroi-
dal vessels were visible (Fig. 1D and 1E)
Case 2
An 11-year-old male patient with NF-1 was referred to 
the Retina Clinic at Uijeongbu St. Mary’s Hospital for an 
ophthalmological examination. The patient had no relatives 
with the same disease and had multiple cutaneous neurofi-
bromas over the body, although these were only systemic 
manifestations. Visual acuity was 1.0 in both eyes, and the 
microscopic examination showed Lisch nodules in both 
eyes. The fundus and FA showed no definite abnormali-
ties in either eye (Fig. 2A-2D). However, the ICGA showed 
multiple hypofluorescent areas with clear borders in the 






Fig. 2. Case 2. Normal fundus was observed (A). Fluoresceine an-
giography showed hypofluorescent areas with blurred demarcation 
(B-D). Indocyanine green angiography (ICGA) showed multiple 
hypofluorescent areas with clear borders in the early phase, which 
remained small in the late phase. The multiple neurofibromas occu-
pying the choroid are able to be detected by the ICGA, but these le-
sions had not yet led to retinal pigmented epithelium abnormalities 
(E).233
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pletely in the late phase (Fig. 2E).
Discussion
Many studies have reported ocular manifestations in 
NF-1 patients, including choroidal abnormalities [9-16]. 
However, most of these cases are included in histopatho-
logic studies or have abnormalities that are definitely 
observable with the fundoscope. Choroidal neurofibroma-
tosis is thought to be a rare form of neurofibromatosis that 
affects the eyes [9,10,14-16]. The actual prevalence of this 
disorder may be higher than currently believed because 
patients with good vision tend not to undergo ocular ex-
aminations. Thus, without an ocular examination, which 
usually involves a conventional ophthalmoscopic exami-
nation or FA, patients with good vision are not tested for 
choroidal abnormalities. In some patients, the choroid 
neurofibromatosis may appear as yellowish nodules, but 
these may appear as bright patched areas upon fundo-
scopic examination in only weakly affected patients. FA 
shows irregular hyperfluorescence that is related to retinal 
pigmented epithelium (RPE) alteration, but it is not able to 
detect underlying choroidal abnormalities. 
ICGA has overcome the limitations of FA in regard to 
imaging of the choroidal structure [17-20]. Several au-
thors have previously reported the presence of choroidal 
neurofibromatosis with the use of ICGA. Yasunari et al. 
[21] have reported that they were able to detect choroidal 
abnormalities in all 17 of their patients with NF-1 using 
scanning laser ophthalmoscopy (SLO) and ICGA, and that 
the choroid was one of the structures most commonly af-
fected by NF-1. They suggested that the hypofluorescent 
areas on the ICGA, that appeared to be obscure with SLO 
and FA in their less affected patients, were probably not 
caused by disturbance of the choriocapillaris circulation, 
but rather by the presence of refractile tissue or material 
in the choroid. They believed that such refractile material 
presumably blocks the fluorescence from the underlying 
choroidal vessels and produces a hypofluorescent appear-
ance which disappears on the ICGA at the late phase due 
to the indocyanine-green dye being extravasated into the 
choroidal stroma. In contrast, Rescaldani et al. [10] have 
suggested in their study that the early hypofluorescent 
areas in the ICGA are due to the hypo- or non-perfused 
lobules of the choriocapillaris rather than the blocking of 
fluorescent light by the neurofibromatose choroidal nod-
ules since these areas became smaller or disappeared in the 
late phase and because the deep choroidal vessels were vis-
ible within these areas. Additionally, one histological study 
has documented that Schwann cell growth with dysplasia 
of the smooth muscle cells of the arteriolar wall leads to 
the gradual narrowing of the vessel lumen [22]. Accord-
ing to Rescaldani et al. [10], chronic hypoperfusion of the 
choriocapillaris appears to cause lesions to the overlying 
RPE and cause its eventual atrophy (yellowish patches on 
ophthalmoscopy that correspond to the hyperfluorescent 
areas in the FA).
In our case 1, the fundus did not show yellowish nodules 
but rather bright patched areas around the posterior pole, 
similar to Yasunari’s cases. These lesions appeared to be 
hyperfluorescent areas in the FA, which suggests RPE 
alterations are present. However, the ICGA showed dif-
fuse hypofluorescence with visible deep choroidal vessels 
from the early phase to the late phase and was unrelated 
to the lesion observed by both fundoscopy and FA. This 
finding is believed to be due to the diffuse scattering of 
the neurofibromatose tissue in the choroid without re-
markable prominence. In regard to case 2, the abnormal 
alterations were not clearly visible by either fundoscopy 
or FA. However, the ICGA showed multiple hypofluores-
cent areas that persisted into the late phase. It is thought 
that multiple neurofibromas occupying the choroid were 
detected by the ICGA, and that these neurofibromas were 
not yet producing RPE abnormalities. However, it is insuf-
ficient to conclude that these abnormalities presented with 
choroidal neurofibromas because various possibilities exist 
for the underlying cause. Choroidal involvement in NF-1 
may occur more often than what is currently believed. 
Also, the underlying cause of this, whether it be due to 
the space-occupying neurofibroma itself or the vascular 
change associated with the neurofibromatosis, may lead to 
the hypoperfusion of the lesion that would later result in 
RPE alteration. We believe that these ICGA patterns that 
are seen in our cases may not be due to hypoperfusion or 
nonperfusion of the choroidal lobules, but due instead to 
blocked fluorescence by the choroid-occupying materials.
In conclusion, these two cases have shown that choroidal 
abnormalities occur more often than currently believed in 
patients with NF-1. Fundoscopic examination can identify 
grossly proliferative neurofibromatosis but only in the later 
stages, and FA can only describe actual RPE alterations, 
secondary to choriocapillaris nonperfusion. However, 
ICGA is a useful tool to detect the early changes that occur 
with choroid abnormalities. Although no abnormal finding 
was found by either fundoscopy or FA, ICGA seems to be 
useful for ocular examinations of NF-1 patients that have 
good vision.
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